News
POAI
--
0.00%
--
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Advancing Solutions for 'Personalized Medicine at Its Finest'
May 06, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology (NASDAQ: POAI) has made several advances in providing cancer treatment solutions. Its...
Investor Brand Network · 2d ago
New Study Finds That Generations X, Y Display Poorer Health Trends
Apr 29, 2021 (Investor Brand Network via COMTEX) -- According to a recent study, Gen X and Y are demonstrating higher levels of unhealthy behaviors and...
Investor Brand Network · 04/29 19:15
Predictive Oncology Files Shelf for Up to $250 Million in Securities
MT Newswires · 04/29 03:25
BRIEF-Predictive Oncology Files For Mixed Shelf Of Up To $250 Mln– SEC Filing
reuters.com · 04/28 22:42
BioMedNewsBreaks - Predictive Oncology Inc.'s (NASDAQ: POAI) Helomics Featured in DojoLIVE! Interview
Apr 27, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology's (NASDAQ: POAI) subsidiary company, Helomics, was recently featured on DojoLIVE!, an...
Investor Brand Network · 04/27 19:10
Predictive Oncology Inc. Announces Newest Board Member
MINNEAPOLIS, April 27, 2021 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, is excited to announce today their newest Board M...
GlobeNewswire · 04/27 13:30
Press Release: Predictive Oncology Inc. Announces Newest Board Member
Dow Jones · 04/27 12:30
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Featured in Bell2Bell Podcast
Apr 21, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial...
Investor Brand Network · 04/21 18:08
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast featuring Mel Engle, CEO of Predictive Oncology Inc.
LOS ANGELES, April 21, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the lates...
GlobeNewswire · 04/21 13:01
Predictive Oncology's (NASDAQ: POAI) Subsidiary Refining, Strengthening Personalized Oncology Approach to Ovarian Cancer
Ovarian cancer ranks fifth in cancer deaths among women, accounting for more deaths than any other cancer of female reproductive system TumorGenesis can...
Investor Brand Network · 04/19 16:08
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Offers Innovative Solution in Multibillion and Growing Market
Apr 16, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology (NASDAQ: POAI), through its Skyline Medical division, is positioned for opportunity...
Investor Brand Network · 04/16 17:50
Study Finds That Sugar Compromises Brain Development in Children
Apr 14, 2021 (Investor Brand Network via COMTEX) -- A recent study conducted by a faculty member from the University of Georgia, in partnership with a team...
Investor Brand Network · 04/14 17:44
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Eyes Expansion of AI-Driven Clinical Models
Investor Brand Network · 04/09 16:23
FUBO, TXMD among premarket gainers
Celcuity (CELC) +55% on licensing agreement up to $340M for breast cancer treatment gedatolisib.Affimed N.V. (AFMD) +29% on positive data from NK cells + AFM13 in solid tumors.Greenwich LifeSciences (GLSI) +29% on robust
Seekingalpha · 04/09 12:33
Predictive Oncology Inc. (NASDAQ: POAI) Taps Its Chairman to be CEO
Current POAI Chairman J. Melville ("Mel") Engle has been appointed to CEO position Engle has held executive positions throughout his career at leading pharma...
Investor Brand Network · 04/05 17:31
ACAD, NNOX, CTRM and DMYD among midday movers
Gainers: Chembio Diagnostics (CEMI) +61%.AeroCentury (ACY) +59%.Xcel Brands (XELB) +54%.dMY Technology (DMYD) +34%.Performant Financial (PFMT) +33%.Nephros (NEPH) +27%.Nano-X Imaging (NNOX) +26%.Regional Health Properties (RHE) +24%.Leaf Group (LEAF) +21%....
Seekingalpha · 04/05 16:40
Chembio Diagnostics, Nano-X Imaging leads healthcare gainers; Molecular Templates, ACADIA Pharmaceuticals among major losers
Gainers: Chembio Diagnostics CEMI +60%, Nano-X Imaging NNOX +25%, NanoVibronix (NAOV) +16%, Vivos Therapeutics (VVOS) +15%, Greenwich LifeSciences (GLSI) +14%.Losers: Molecular Templates (MTEM) -26%, ACADIA Pharmaceuticals ACAD -17%, Benitec Biopharma (BNT...
Seekingalpha · 04/05 15:00
Best Penny Stocks to Buy Right Now? 3 To Watch As Biotech Rebounds
Penny Stocks · 04/04 13:06
Researchers Find That Birth Control Pills May Protect Female Athletes from Concussions
Apr 01, 2021 (Investor Brand Network via COMTEX) -- A pilot study that was conducted recently by Northwestern Medicine has discovered that when a female...
Investor Brand Network · 04/01 16:14
BioMedNewsBreaks - Predictive Oncology Inc. (NASDAQ: POAI) Leverages Multi-Omic Approach to New Drug Discovery
Mar 30, 2021 (Investor Brand Network via COMTEX) -- Predictive Oncology (NASDAQ: POAI) is a knowledge-driven company focused on applying data and artificial...
Investor Brand Network · 03/30 15:06
Webull provides a variety of real-time POAI stock news. You can receive the latest news about Predictive Oncology Inc through multiple platforms. This information may help you make smarter investment decisions.
About POAI
Predictive Oncology Inc. is focused on applying artificial intelligence (AI) to personalized medicine and drug discovery. It operates through its subsidiaries, Helomics Holding Corporation (Helomics), TumorGenesis Inc., Skyline Europe and Skyline Medical Inc. Helomics applies AI to its data gathered from patient tumors to both personalize cancer therapies for patients and focusses on the development of new-targeted therapies. Helomics’ clinical laboratory improvement amendments (CLIA)-certified lab provides clinical testing that assists oncologists in individualizing patient treatment decisions. Its TumorGenesis Inc. is engaged in developing approach to tumors in the laboratory. Skyline Medical Inc. markets its STREAMWAY System, which automates the collection, measurement and disposal of waste fluid, including blood, irrigation fluid and others, within a medical facility, through both domestic and international divisions.